Align Technology | ALGN - Equity Capital And Reserves


Align Technology reported $4.15B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
3M USD 3.26B 1.48B Mar/2026
Align Technology USD 4.15B 100.27M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Cardinal Health USD -2.83B 52M Mar/2026
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
CVS Health USD 77.46B 2.24B Mar/2026
Danaher USD 52.95B 415M Mar/2026
Dentsply International USD 1.32B 21M Mar/2026
Dexcom USD 2.96B 210.9M Mar/2026
Henry Schein USD 3.27B 21M Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
McKesson USD -2.17B 874M Mar/2026
Mettler Toledo International USD -41.88M 18.25M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Solventum Corp USD 4.97B 80M Mar/2026
Stryker USD 22.42B 635M Dec/2025
Teleflex USD 3.08B 40.33M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Veeva Systems USD 7.3B 89.6M Mar/2026
Waters USD 2.56B 230.55M Dec/2025
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026
Zoetis USD 3.23B 98M Mar/2026